Morgan Stanley’s SurgePays SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$751 Hold
1,000
﹤0.01% 7509
2025
Q4
$1.67K Hold
1,000
﹤0.01% 7282
2025
Q3
$2.81K Hold
1,000
﹤0.01% 7230
2025
Q2
$3.11K Sell
1,000
-99
-9% -$274 ﹤0.01% 7144
2025
Q1
$2.27K Buy
1,099
+99
+10% +$146 ﹤0.01% 7147
2024
Q4
$1.78K Hold
1,000
﹤0.01% 7217
2024
Q3
$1.84K Hold
1,000
﹤0.01% 7146
2024
Q2
$3.19K Sell
1,000
-7,700
-89% -$29.1K ﹤0.01% 6965
2024
Q1
$33.5K Buy
8,700
+8,300
+2,075% +$55.4K ﹤0.01% 6350
2023
Q4
$2.58K Buy
+400
New +$2.13K ﹤0.01% 7104
2023
Q3
Sell
-400
Closed -$2.92K 7700
2023
Q2
$2.92K Hold
400
﹤0.01% 7113
2023
Q1
$1.8K Sell
400
-2
-0.5% -$11 ﹤0.01% 7256
2022
Q4
$2.64K Buy
402
+2
+0.5% +$12 ﹤0.01% 7301
2022
Q3
$2K Hold
400
﹤0.01% 7489
2022
Q2
$2K Sell
400
-26
-6% -$110 ﹤0.01% 7609
2022
Q1
$2K Buy
+426
New +$1.31K ﹤0.01% 7761

Other funds holding SURG

Morgan Stanley's SURG Position: Q1 2026 in Review

Morgan Stanley held its SurgePays (SURG) position steady in Q1 2026 at 1,000 shares worth $751. The position accounts for ﹤0.01% of the portfolio, ranked #7509.

Morgan Stanley first reported a position in SURG in Q1 2022 and has held it in 16 quarters since. The position peaked at $33.5K in Q1 2024. 33 funds tracked by Wall St. Rank hold SURG as of Q1 2026.

  • Morgan Stanley held 1,000 shares of SurgePays worth $751 as of Q1 2026.
  • Morgan Stanley left its SurgePays share count unchanged in Q1 2026.
  • SurgePays made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7509 holding.
  • Morgan Stanley first reported a position in SurgePays in Q1 2022 and has held it in 16 quarters since.
  • Morgan Stanley's SurgePays position peaked at $33.5K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held SurgePays as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.